Literature DB >> 29893570

Characterization of Metabolomic Profile Associated with Metabolic Improvement after Bariatric Surgery in Subjects with Morbid Obesity.

Magali Palau-Rodriguez1,2, Sara Tulipani1,3, Anna Marco-Ramell1,2, Antonio Miñarro4, Olga Jauregui1,5, Raul Gonzalez-Dominguez1,2, Alex Sanchez-Pla4,6, Bruno Ramos-Molina3,7, Francisco J Tinahones3,7, Cristina Andres-Lacueva1,2.   

Abstract

The exact impact of bariatric surgery in metabolically "healthy" (MH) or "unhealthy" (MU) phenotypes for the study of the metabolic improvement is still unknown. We applied an untargeted LC-ESI-TripleTOF-MS-driven metabolomics approach in serum samples from 39 patients with morbid obesity (MH and MU) 1, 3, and 6 months after bariatric surgery. Multiple factor analysis, along with correlation and enrichment analyses, was carried out to distinguish those metabolites associated with metabolic improvement. Hydroxypropionic acids, medium-/long-chain hydroxy fatty acids, and bile acid glucuronides were the most discriminative biomarkers of response between MH and MU phenotypes. Hydroxypropionic (hydroxyphenyllactic-related) acids, amino acids, and glycerolipids were the most significant clusters of metabolites altered after bariatric surgery in MU ( p < 0.001). After surgery, MU and MH changed toward a common metabolic state 3 months after surgery. We observed a negative correlation with changes in waist circumference and cholesterol levels with metabolites of lipid metabolism. Glycemic variables were correlated with hexoses, which, in turn, correlated with gluconic acid and amino acid metabolism. Finally, we noted that hydroxyphenyllactic acid was associated with amino acid and lipid metabolism. Microbial metabolism of amino acid and BA glucuronidation pathways may be the key points of metabolic rearrangement after surgery.

Entities:  

Keywords:  bariatric surgery; hydroxyphenyllactic; indole metabolites; mass spectrometry; metabolically healthy; microbiota metabotype; obesity; untargeted metabolomics

Mesh:

Substances:

Year:  2018        PMID: 29893570     DOI: 10.1021/acs.jproteome.8b00144

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  5 in total

Review 1.  Metabolomics prospect of obesity and metabolic syndrome; a systematic review.

Authors:  Moloud Payab; Akram Tayanloo-Beik; Khadijeh Falahzadeh; Maryamossadat Mousavi; Saeede Salehi; Shirin Djalalinia; Mahbube Ebrahimpur; Nafiseh Rezaei; Mostafa Rezaei-Tavirani; Bagher Larijani; Babak Arjmand; Kambiz Gilany
Journal:  J Diabetes Metab Disord       Date:  2021-11-26

2.  Metabolomics in Bariatric and Metabolic Surgery Research and the Potential of Deep Learning in Bridging the Gap.

Authors:  Athanasios G Pantelis
Journal:  Metabolites       Date:  2022-05-19

3.  A role for foregut tyrosine metabolism in glucose tolerance.

Authors:  Judith Korner; Gary W Cline; Mark Slifstein; Pasquale Barba; Gina R Rayat; Gerardo Febres; Rudolph L Leibel; Antonella Maffei; Paul E Harris
Journal:  Mol Metab       Date:  2019-02-27       Impact factor: 7.422

4.  Lipidomic Profile Revealed the Association of Plasma Lysophosphatidylcholines with Adolescent Obesity.

Authors:  Yang Wang; Chang-Tao Jiang; Jie-Yun Song; Qi-Ying Song; Jun Ma; Hai-Jun Wang
Journal:  Biomed Res Int       Date:  2019-12-13       Impact factor: 3.411

5.  Managing the Unpredictable: Mechanistic Analysis and Clinical Recommendations for Lamotrigine Treatment after Bariatric Surgery.

Authors:  Daniel Porat; Carmil Azran; Hasan Kais; Arik Dahan
Journal:  J Clin Med       Date:  2021-11-29       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.